This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Connor, B. M. Articles by Galivan, J. Search for Related Content PubMed PubMed Citation Articles by O'Connor, B. M. Articles by Galivan, J.

Secretion of -Glutamyl Hydrolase in Vitro¹

Wadsworth Center for Laboratories and Research, New York State Department of Health, Albany, New York 12201-0509 [B. M. O. C., R. F. R., Z. N., J. G.]; Department of Biomedical Sciences, School of Public Health, University at Albany, State University, Albany, New York 12201-0509 [R. F. R., J. G.]; and Grace Cancer Drug Center, Roswell Park Memorial Institute, Buffalo, New York 14263 [J. J. M.]

-Glutamyl hydrolase (also known as conjugase) is a ubiquitous enzyme that has the capacity to cleave folyl- and antifolylpolyglutamates. This study has revealed that the enzyme is secreted by primary cultures of rat hepatocytes and by H35 hepatoma cells. H35 cells have lower cellular levels of -glutamyl hydrolase than do hepatocytes but secrete a greater proportion of -glutamyl hydrolase. More than 99% of the total enzyme from H35 cells accumulated in the medium after 48 h. The cells were shown to remain intact during the secretion period since lactate dehydrogenase, dihydrofolate reductase, and lysosomal hydrolases other than -glutamyl hydrolase were retained within the cell. Using the substrate 4-amino-10-methyl-pteroyldiglutamate (4-NH₂-10-CH₃-Pte-Glu₂), the intracellular and secreted enzyme form(s) from H35 cells were found to have the following properties (a) K_m values of 24.3 ± 3.7 µM and 34.8 ± 8.6 µM, respectively, and (b) maximal activity at pH 5 to 7 and apparent molecular weights of 120,000 by gel filtration. Both the cellular and secreted enzymes convert 4-NH₂-10-CH₃-PteGlu₄ and pteroylpentaglutamate acid, to the corresponding monoglutamates with little or no appearance of intermediate chain length polyglutamates. This suggests that both act primarily as endopeptidases. Thus far, the cellular and secreted enzymes cannot be differentiated although the current studies do not establish this point unequivocally. Alterations in the cellular and secreted H35 cell -glutamyl hydrolase levels in response to changes in culture conditions revealed that glutamine enhances activity while insulin diminishes it. Other transformed cells found to secrete this protein are Hep-G2 human hepatoma, JAR human choriocarcinoma, HeLa, and rat glioma. -Glutamyl hydrolase could not be detected in medium conditioned by human MCF-7 breast cancer cells, and relatively low activities were found in the medium from CCRF-CEM or K562 leukemia cells. These studies directly establish for the first time the secretion of -glutamyl hydrolase in vitro.

¹ This work was supported by NIH Grants CA16056 (J. J. M.), CA43500 (J. J. M.), CA25933 (J. G.), CA34314 (J. G.), and CA46126 (J. G.).

Received 2/26/91. Accepted 5/24/91.

This article has been cited by other articles:

				I. Ifergan, G. Jansen, and Y. G. Assaraf The Reduced Folate Carrier (RFC) Is Cytotoxic to Cells under Conditions of Severe Folate Deprivation: RFC AS A DOUBLE EDGED SWORD IN FOLATE HOMEOSTASIS J. Biol. Chem., July 25, 2008; 283(30): 20687 - 20695. [Abstract] [Full Text] [PDF]

				K. Fotoohi, G. Jansen, Y. G. Assaraf, L. Rothem, M. Stark, I. Kathmann, J. Gregorczyk, G. J. Peters, and F. Albertioni Disparate mechanisms of antifolate resistance provoked by methotrexate and its metabolite 7-hydroxymethotrexate in leukemia cells: implications for efficacy of methotrexate therapy Blood, December 15, 2004; 104(13): 4194 - 4201. [Abstract] [Full Text] [PDF]

				E. Odin, Y. Wettergren, S. Nilsson, R. Willen, G. Carlsson, C. P. Spears, L. Larsson, and B. Gustavsson Altered Gene Expression of Folate Enzymes in Adjacent Mucosa Is Associated with Outcome of Colorectal Cancer Patients Clin. Cancer Res., December 1, 2003; 9(16): 6012 - 6019. [Abstract] [Full Text] [PDF]

				E. L. Volk, K. Rohde, M. Rhee, J. J. McGuire, L. A. Doyle, D. D. Ross, and E. Schneider Methotrexate Cross-Resistance in a Mitoxantrone-selected Multidrug-resistant MCF7 Breast Cancer Cell Line Is Attributable to Enhanced Energy-dependent Drug Efflux Cancer Res., July 1, 2000; 60(13): 3514 - 3521. [Abstract] [Full Text]

				G. Jansen, H. Barr, I. Kathmann, M. A. Bunni, D. G. Priest, P. Noordhuis, G. J. Peters, and Y. G. Assaraf Multiple Mechanisms of Resistance to Polyglutamatable and Lipophilic Antifolates in Mammalian Cells: Role of Increased Folylpolyglutamylation, Expanded Folate Pools, and Intralysosomal Drug Sequestration Mol. Pharmacol., April 1, 1999; 55(4): 761 - 769. [Abstract] [Full Text]

				M. G. Rots, R. Pieters, G. J. Peters, P. Noordhuis, C. H. van Zantwijk, G. J.L. Kaspers, K. Hahlen, U. Creutzig, A. J.P. Veerman, and G. Jansen Role of Folylpolyglutamate Synthetase and Folylpolyglutamate Hydrolase in Methotrexate Accumulation and Polyglutamylation in Childhood Leukemia Blood, March 1, 1999; 93(5): 1677 - 1683. [Abstract] [Full Text] [PDF]

				A. Tse and R. G. Moran Cellular Folates Prevent Polyglutamation of 5,10-Dideazatetrahydrofolate. A NOVEL MECHANISM OF RESISTANCE TO FOLATE ANTIMETABOLITES J. Biol. Chem., October 2, 1998; 273(40): 25944 - 25952. [Abstract] [Full Text] [PDF]

				M. C. Waltham, W.-W. Li, H. Gritsman, W. P. Tong, and J. R. Bertino gamma -Glutamyl Hydrolase from Human Sarcoma HT-1080 Cells: Characterization and Inhibition by Glutamine Antagonists Mol. Pharmacol., May 1, 1997; 51(5): 825 - 832. [Abstract] [Full Text]

				R. Yao, Z. Nimec, T. J. Ryan, and J. Galivan Identification, Cloning, and Sequencing of a cDNA Coding for Rat [IMAGE]-Glutamyl Hydrolase J. Biol. Chem., April 12, 1996; 271(15): 8525 - 8528. [Abstract] [Full Text] [PDF]